日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ubiquitin-mediated stabilization of KDM5B drives chemoresistance via repression of dual-specificity phosphatase 4 in ovarian cancer

泛素介导的KDM5B稳定化通过抑制双特异性磷酸酶4驱动卵巢癌的化疗耐药性

Jung Yoo,Go Woon Kim,Yu Hyun Jeon,Jaewook Kim,Enzhi Luo,Sang Wu Lee,Soo Yeon Oh,Junjeong Choi,Kuglae Kim,So Hee Kwon

KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis.

KDM5B 驱动的葡萄糖代谢重编程通过乳酸/hnRNPA1 乳酸化/AR-V7 轴促进前列腺癌对恩扎卢胺的耐药性。

Sun Rui, Huang Yong, He Hao, Li Qiuchen, Wang Linfeng, Zhang Gaojie, Wei Ziling, Cao Yang, Li Jing, Wang Xianmin, Yang Fan, Chen Wenjun, Li Xiang, Yu Jiang, Liu Siyuan, Lei Congfeng, Jiang Yu, Peng Yueqiang, Su Huiyi, Gao Yingying, He Weiyang, Yang Lei, Liu Jiayu

KDM5B cooperates with CRL4B complex to promote the tumorigenesis of ER+ breast cancer via regulating cholesterol metabolism

KDM5B与CRL4B复合物协同作用,通过调节胆固醇代谢促进ER阳性乳腺癌的肿瘤发生。

Yang, Yunkai; Gao, Tianyang; Yuan, Baowen; Hao, Xinhui; Huo, Miaomiao; Hu, Ting; Ma, Tianyu; Zhang, Min; Zhang, Die; Teng, Xu; Yu, Hefen; Huang, Wei; Zhang, Jingyao; Wang, Yan

The role of KDM5B in creating synthetic vulnerabilities in combination with radiotherapy in melanoma cells

KDM5B在黑色素瘤细胞放射疗法联合作用下产生合成脆弱性的作用

Larafa, Safa; Schaffrin, Merle; Braß, Peer; Váraljai, Renáta; Scharfenberg, Sarah; Kravchenko-Balasha, Nataly; Polinovski, Gil; Herlyn, Meenhard; Tarade, Nooraldeen; Wiemann, Stefan; Roesch, Alexander; Schadendorf, Dirk; Jendrossek, Verena; Matschke, Johann; Shannan, Batool

Integrated Multi-Omic Analysis Reveals KDM5B as a Regulator of Microglial Reactivity to Immunomodulatory Stimuli

整合多组学分析揭示KDM5B是小胶质细胞对免疫调节刺激反应的调节因子

Wohlfahrt, Jessica; Wolf, Tiara; Winters, Alexis M; Burkhardt, Brant R; Liu, Bin; Guergues, Jennifer; Stevens, Stanley M Jr

KDM5B recruits FOXG1 to suppress the IFN response, leading to malignant progression and immune evasion in cervical cancer

KDM5B 募集 FOXG1 以抑制 IFN 反应,从而导致宫颈癌的恶性进展和免疫逃逸。

He, Guangping; Liang, Jiali; Ding, Ziyang; Qu, Xinyu; Qiu, Junjun

Suppressing the OTUD7A/KDM5B/GABPA axis enhances the sensitivity of cisplatin through inducing ferroptosis in KRAS-mutant LUAD.

抑制 OTUD7A/KDM5B/GABPA 轴可通过诱导 KRAS 突变型 LUAD 中的铁死亡来增强顺铂的敏感性。

de novo KDM5B Mutation in a Patient with Autism Spectrum Disorder and Obsessive-Compulsive Disorder: Case Report

自闭症谱系障碍合并强迫症患者的新生KDM5B基因突变:病例报告

Sabetfakhri, Niki P; Guter, Stephen J Jr; Reyes Pinzon, Sandra H; Ajilore, Olusola A; Cook, Edwin H; Najjar, Fedra

Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis

去泛素化酶USP7通过ZBTB16/TOP2A轴稳定KDM5B,促进鼻咽癌的肿瘤进展和顺铂耐药性。

Zhang, Bin; Li, Jie; Wang, Yijun; Liu, Xixi; Yang, Xiao; Liao, Zhiyun; Deng, Suke; Deng, Yue; Zhou, Zhiyuan; Tian, Yu; Wei, Wenwen; Meng, Jingshu; Hu, Yan; Wan, Chao; Zhang, Zhanjie; Huang, Fang; Wen, Lu; Wu, Bian; Sun, Yajie; Li, Yan; Yang, Kunyu

Isorhamnetin Alleviates Mitochondrial Injury in Severe Acute Pancreatitis via Modulation of KDM5B/HtrA2 Signaling Pathway

异鼠李素通过调节KDM5B/HtrA2信号通路减轻重症急性胰腺炎中的线粒体损伤

Li, Xiaojuan; Wang, Tao; Zhou, Qilong; Li, Fan; Liu, Ting; Zhang, Kun; Wen, Ao; Feng, Lijuan; Shu, Xiaoling; Tian, Simin; Liu, Yijiang; Gao, Yu; Xia, Qing; Xin, Guang; Huang, Wen